Dawn L. Hershman on Factors Contributing to CIPN
Dawn L. Hershman, MD, MS, Columbia University Medical Center, discusses the results of a recent study that found diabetes, age, and certain treatment regimens are contributing factors to developing chemotherapy-induced peripheral neuropathy (CIPN).
The study, which examined more than 1400 patients over the age of 65, reports that CIPN rates increase with age, and patients with diabetes treated with a taxane had nearly a twofold risk of developing CIPN, as were those treated with paclitaxel versus docetaxel.
Conversely, patients who had an autoimmune disease actually showed lower rates of CIPN, which, Hershman notes, raises intriguing questions for further study.
Nursing Perspectives on Managing Toxicities With ADCs in Metastatic Gastric and Breast Cancers
September 1st 2022In this episode of "The Vitals," Sarah Donahue, MPH, NP, AOCNP; Jamie Carroll, APRN, CNP, MSN; Theresa Wicklin Gillespie, PhD, MA, RN, FAAN; and Elizabeth Prechtel-Dunphy, DNP, RN, ANP-BC, AOCN, exchange clinical pearls for treating patients receiving antibody-drug conjugates.
Increasing Awareness of Audiovestibular Adverse Events From Immune Checkpoint Inhibitors
July 16th 2024Oncology nurses play a critical role in identifying and managing rare audiovestibular complications associated with immune checkpoint inhibitors to prevent permanent hearing loss and improve patients' quality of life.
